NOVEL IMMUNOMODULATOR AND ANTI INFLAMMATORY COMPOUNDS

(19)

(11)

EP 2 566 847 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	27.03.2019 Bulletin 2019/13

(45)	Mention of the grant of the patent:
	07.11.2018 Bulletin 2018/45

(21)	Application number: 11738472.7

(22)	Date of filing: 06.05.2011

(51)

International Patent Classification (IPC):

C07D 209/14^(2006.01)
C07D 213/81^(2006.01)
C07D 241/24^(2006.01)
C07D 317/58^(2006.01)
C07C 233/66^(2006.01)
A61K 31/167^(2006.01)
A61K 31/4965^(2006.01)
A61P 35/00^(2006.01)

C07D 213/75^(2006.01)
C07D 213/56^(2006.01)
C07D 307/79^(2006.01)
C07D 319/18^(2006.01)
C07C 235/84^(2006.01)
A61K 31/44^(2006.01)
A61P 19/02^(2006.01)

(86)	International application number:
	PCT/IB2011/000959

(87)	International publication number:
	WO 2011/138665 (10.11.2011 Gazette 2011/45)

(54)	NOVEL IMMUNOMODULATOR AND ANTI INFLAMMATORY COMPOUNDS NEUARTIGE IMMUNMODULATOREN UND ENTZÜNDUNGSHEMMENDE VERBINDUNGEN NOUVEAUX COMPOSÉS IMMUNOMODULATEURS ET ANTI-INFLAMMATOIRES

(84)	Designated Contracting States:
	AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30)

Priority:

06.05.2010 IN 1265CH2010

(43)	Date of publication of application:
	13.03.2013 Bulletin 2013/11

(73)	Proprietors:
	Incozen Therapeutics Pvt. Ltd. Hyderabad 500 078 (IN) Rhizen Pharmaceuticals S.A. 2300 La Chaux de Fonds (CH)

(72)	Inventors:
	MUTHUPPALANIAPPAN, Meyyappan Hyderabad 500 078 (IN) BHAVAR, Prashnant, Kashinath Hyderabad 500 078 (IN) VISWANADHA, Srikant Hyderabad 500 078 (IN) VAKKALANKA, Swaroop, Kumar, V.S. CH-2300 La Chaux-de-Fonds (IN) MERIKAPUDI, Gayatri, Swaroop Hyderabad 500 078 (IN)

(74)	Representative: Pons
	Glorieta Ruben Dario 4 28010 Madrid 28010 Madrid (ES)

(56)

References cited: :

EP-A1- 2 135 610
WO-A2-03/006425
US-A- 2 474 893

WO-A1-2011/026107
DE-C- 887 501

SHINJI ANDO ET AL: "Substituent shielding parameters of fluorine-19 NMR on polyfluoroaromatic compounds dissolved in dimethyl sulphoxide-d6", MAGNETIC RESONANCE IN CHEMISTRY, vol. 33, no. 8, 1 August 1995 (1995-08-01) , pages 639-645, XP55005140, ISSN: 0749-1581, DOI: 10.1002/mrc.1260330805
SERCHENKOVA S V ET AL: "IR spectroscopic study of compounds of benzimide-amido-acid series", POLYMER SCIENCE U.S.S.R, PERGAMON, vol. 18, no. 8, 1 January 1976 (1976-01-01), pages 2133-2141, XP024123389, ISSN: 0032-3950, DOI: 10.1016/0032-3950(76)90402-0 [retrieved on 1976-01-01]
RUSCHIG H ET AL: "2,6-DIHYDROXYBENZOESAEUREDERIVATE ALS ANTHELMINTHIKA//2,6-DIHYDROXYBE NZOIC ACID DERIVATIVES AS ANTHELIMINTICS", ARZNEIMITTEL FORSCHUNG. DRUG RESEARCH, ECV EDITIO CANTOR VERLAG, AULENDORF, DE, vol. 23, no. 12, 1 January 1973 (1973-01-01), pages 1745-1758, XP009044195, ISSN: 0004-4172
HARTMANN R W ET AL: "SYNTHESIS AND AROMATASE INHIBITION OF 3-CYCLOALKYL-SUBSTITUTED 3-(4-AMINOPHENYL)PIPERIDINE-2,6-DIONES", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, vol. 35, no. 12, 12 June 1992 (1992-06-12) , pages 2210-2214, XP000615592, ISSN: 0022-2623, DOI: 10.1021/JM00090A010
JOHN S. SWENTON ET AL: "Preparation of quinol N-acyl- and quinol ether imines via anodic oxidation of para-substituted anilide derivatives", THE JOURNAL OF ORGANIC CHEMISTRY, vol. 58, no. 21, 1 October 1993 (1993-10-01), pages 5607-5614, XP55005169, ISSN: 0022-3263, DOI: 10.1021/jo00073a016

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).